Vg Life Sciences Inc
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is … Read more
Market Cap & Net Worth: Vg Life Sciences Inc (VGLS)
Vg Life Sciences Inc (PINK:VGLS) has a market capitalization of $2.11 Million ($2.11 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51361 globally and #16051 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vg Life Sciences Inc's stock price $0.00 by its total outstanding shares 21095499776 (21.10 Billion).
Vg Life Sciences Inc Market Cap History: 2015 to 2024
Vg Life Sciences Inc's market capitalization history from 2015 to 2024. Data shows change from $527.39 Million to $2.11 Million (-42.32% CAGR).
Vg Life Sciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vg Life Sciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VGLS by Market Capitalization
Companies near Vg Life Sciences Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Vg Life Sciences Inc by market ranking:
- China Overseas Land Investment (PINK:CAOVY): Ranked #970 globally with a market cap of $20.11 Billion USD.
- CK Asset Holdings Limited (PINK:CNGKY): Ranked #1274 globally with a market cap of $14.49 Billion USD.
- Sun Hung Kai Properties Limited (PINK:SUHJF): Ranked #1395 globally with a market cap of $12.91 Billion USD.
- Sun Hung Kai Properties Ltd (PINK:SUHJY): Ranked #1450 globally with a market cap of $12.29 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #970 | China Overseas Land Investment | PINK:CAOVY | $20.11 Billion | $8.41 |
| #1274 | CK Asset Holdings Limited | PINK:CNGKY | $14.49 Billion | $7.65 |
| #1395 | Sun Hung Kai Properties Limited | PINK:SUHJF | $12.91 Billion | $9.56 |
| #1450 | Sun Hung Kai Properties Ltd | PINK:SUHJY | $12.29 Billion | $9.10 |
Vg Life Sciences Inc Historical Marketcap From 2015 to 2024
Between 2015 and today, Vg Life Sciences Inc's market cap moved from $527.39 Million to $ 2.11 Million, with a yearly change of -42.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $2.11 Million | 0.00% |
| 2023 | $2.11 Million | 0.00% |
| 2022 | $2.11 Million | -90.00% |
| 2021 | $21.10 Million | -79.17% |
| 2020 | $101.26 Million | -18.64% |
| 2019 | $124.46 Million | -11.94% |
| 2018 | $141.34 Million | -33.00% |
| 2017 | $210.95 Million | +66.67% |
| 2016 | $126.57 Million | -76.00% |
| 2015 | $527.39 Million | -- |
End of Day Market Cap According to Different Sources
On Apr 5th, 2025 the market cap of Vg Life Sciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.11 Million USD |
| MoneyControl | $2.11 Million USD |
| MarketWatch | $2.11 Million USD |
| marketcap.company | $2.11 Million USD |
| Reuters | $2.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.